Methods and related compositions for reduction of fat
Abstract
Compositions and methods useful in the reduction of localized fat deposits in patients in need thereof using pharmacologically active detergents are disclosed. The pharmacologically active detergent compositions can additionally include anti-inflammatory agents, analgesics, dispersion or anti-dispersion agents and pharmaceutically acceptable excipients. The pharmacologically active detergent compositions are useful for treating localized accumulations of fat including, for example, lower eyelid fat herniation, lipodystrophy and fat deposits associated with cellulite and do not require surgical procedures such as liposuction.
Claims
exact text as granted — not AI-modified1 - 53 . (canceled)
54 . A non-surgical method for improving the appearance of a human having a localized fat accumulation and desiring the removal thereof, said method comprises local administration to said fat accumulation a composition consisting essentially of a detergent and phosphatidylcholine, which detergent is deoxycholic acid, or a salt thereof, wherein said detergent reduces the localized fat accumulation thereby improving the appearance of said human, and wherein said detergent is contained in excess of phosphatidylcholine by mass.
55 . A non-surgical method for improving the appearance of a human having a localized fat accumulation and desiring the removal thereof, said method comprises local administration to said fat accumulation a composition comprising a detergent and phosphatidylcholine, which detergent is deoxycholic acid, or a salt thereof, wherein said detergent reduces the localized fat accumulation thereby improving the appearance of said human, and wherein said detergent is contained in excess of phosphatidylcholine by mass.
56 . The method of claim 54 or 55 , wherein said fat accumulation is localized in an area selected from the group consisting of: a thigh, the abdomen, the buttock, calf, an ankle, the upper back, the chin, an arm, the waist, and the hip.
57 . A method for treating a patient having lipomas comprising local administration to said lipomas of said patient a composition consisting essentially of a detergent and phosphatidylcholine, which detergent is deoxycholic acid, or a salt thereof, wherein said detergent reduces the size of said lipomas thereby treating said patient, and wherein said detergent is contained in excess of phosphatidylcholine by mass.
58 . A method for treating a patient having lipomas comprising local administration to said lipomas of said patient a composition comprising a detergent and phosphatidylcholine, which detergent is deoxycholic acid, or a salt thereof, wherein said detergent reduces the size of said lipomas thereby treating said patient, and wherein said detergent is contained in excess of phosphatidylcholine by mass.
59 . The method of any one of claims 54 , 57 , and 58 , wherein the concentration of the detergent is up to 5% (w/v) deoxycholic acid or the salt thereof.
60 . The method of any one of claims 54 , 57 , and 58 , wherein the concentration of the detergent is about 0.1%, 0.5%, or 1% (w/v) deoxycholic acid or the salt thereof.
61 . The method of any one of claims 54 , 57 , and 58 , wherein said salt is sodium salt.
62 . The method of any one of claims 54 , 57 , and 58 , wherein said local administration comprises subcutaneous injection.
63 . The method of any one of claims 54 , 57 , and 58 , wherein said composition further comprises a penetration enhancer.
64 . The method of any one of claims 54 , 57 , and 58 , wherein said composition further comprises hyaluronidase and/or collagenase.
65 . The method of any one of claims 54 , 57 , and 58 , wherein said composition further comprises an active ingredient which is not phosphatidylcholine.
66 . The method of claim 65 , wherein said active ingredient is an anti-inflammatory agent and/or an analgesic.
67 . The method of claim 65 , wherein said active agent is an analgesic.
68 . The method of claim 67 , wherein said analgesic is lidocaine.
69 . The method of any one of claims 54 , 57 , and 58 , wherein the ratio of the detergent to phosphatidylcholine is 1:0.5.
70 . The method of any one of claims 54 , 57 , and 58 , wherein the ratio of the detergent to phosphatidylcholine is 1:0.05.
71 . The method of any one of claims 54 , 57 , and 58 , wherein the ratio of the detergent to phosphatidylcholine is 1:0.005.
72 . A method for non-surgical removal of a localized fat deposit in a patient having such deposit and desiring to remove such deposit, which method comprises contacting the fat deposit with a composition comprising an effective amount of deoxycholic acid or a salt thereof, phosphatidylcholine and a pharmaceutically acceptable excipient, and wherein said deoxycholic acid or the salt thereof is contained in excess of phosphatidylcholine by mass.
73 . A method for non-surgical removal of a localized fat deposit in a patient having such deposit and desiring to remove such deposit, which method comprises contacting the fat deposit with a composition consisting essentially of an effective amount of deoxycholic acid or a salt thereof, phosphatidylcholine and a pharmaceutically acceptable excipient, and wherein said deoxycholic acid or the salt thereof is contained in excess of phosphatidylcholine by mass.
74 . A cosmetic method for non-surgical removal of a localized fat deposit in a patient having such deposit and desiring to remove such deposit, which method comprises contacting the fat deposit with a composition comprising an effective amount of deoxycholic acid or a salt thereof, phosphatidylcholine and a pharmaceutically acceptable excipient, and wherein said deoxycholic acid or the salt thereof is contained in excess of phosphatidylcholine by mass.
75 . A cosmetic method for non-surgical removal of a localized fat deposit in a patient having such deposit and desiring to remove such deposit, which method comprises contacting the fat deposit with a composition consisting essentially of an effective amount of deoxycholic acid or a salt thereof, phosphatidylcholine and a pharmaceutically acceptable excipient, and wherein said deoxycholic acid or the salt thereof is contained in excess of phosphatidylcholine by mass.
76 . A syringe for subcutaneous injection wherein said syringe comprises a sterile aqueous composition comprising a fat removing effective amount of up to 5% (w/v) of a detergent which is deoxycholic acid or a salt thereof, and phosphatidylcholine, wherein the detergent is contained in excess of phosphatidylcholine by mass.
77 . The syringe of claim 76 , further containing at least another active ingredient.
78 . The syringe of claim 76 , wherein the fat removing effective amount is from 0.05% to 5% (w/v).
79 . The syringe of claim 76 , wherein the detergent is the salt of deoxycholic acid.
80 . The syringe of claim 76 , wherein the salt is sodium deoxycholate.
81 . A composition comprising an adipose cell and aqueous solution of a fat removing bile acid or a salt thereof at a concentration of no more than 5% (w/v) and phosphatidylcholine, wherein the bile acid or the salt thereof is contained in excess of phosphatidylcholine by mass.
82 . The composition of claim 81 , wherein the concentration of the bile acid or the salt is from 0.05% to 5% (w/v).
83 . The composition of claim 82 , wherein the bile acid is deoxycholic acid.
84 . The composition of claim 82 , wherein the bile acid salt is sodium deoxycholate.Join the waitlist — get patent alerts
Track US2011002896A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.